We are live on ! Find out more
BDSX icon

Biodesix

7.56 USD
-0.74
8.92%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
7.56
0.00
0%
1 day
-8.92%
5 days
-23.33%
1 month
-68.33%
3 months
-68.54%
6 months
-47.39%
Year to date
17.03%
1 year
16.13%
5 years
-93.75%
10 years
-97.05%
 

About: Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Employees: 334

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 22.6%
Neutral 67.7%
Negative 9.7%
Neutral
Business Wire
10 hours ago
BDSX Investors Have Opportunity to Join Biodesix, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $BDSX--BDSX Investors Have Opportunity to Join Biodesix, Inc. Fraud Investigation with SBS Law.
BDSX Investors Have Opportunity to Join Biodesix, Inc. Fraud Investigation with SBS Law
Neutral
GlobeNewsWire
1 day ago
Biodesix (BDSX) Shareholder Alert: Johnson Fistel Investigates Following Sales Force Challenges
SAN DIEGO, Nov. 20, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a national shareholder rights law firm with an office in Denver, Colorado, has begun investigating potential securities claims on behalf of Biodesix, Inc. (NASDAQ: BDSX) investors following the Company's sharp stock decline on November 6, 2026. The investigation concerns whether Biodesix, a Louisville, Colorado-based diagnostic solutions company, or its officers made materially false or misleading statements or failed to disclose material information to investors.
Biodesix (BDSX) Shareholder Alert: Johnson Fistel Investigates Following Sales Force Challenges
Neutral
PRNewsWire
2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodesix, Inc. - BDSX
NEW YORK, Nov. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biodesix, Inc. ("Biodesix" or the "Company") (NASDAQ: BDSX).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodesix, Inc. - BDSX
Neutral
Business Wire
4 days ago
BIODESIX, INC. BDSX INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 57% Share Drop
NEW YORK--(BUSINESS WIRE)---- $BDSX #ClassActionLawsuit--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM'S INVESTIGATION]What Happened?On November 5, 2026, Biodesix announced its third quarter 2026 financial results, reporting third quarte.
BIODESIX, INC. BDSX INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 57% Share Drop
Neutral
GlobeNewsWire
4 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodesix, Inc. - BDSX
NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodesix, Inc. - BDSX
Neutral
GlobeNewsWire
5 days ago
Biodesix (BDSX) Shares Plunge; Johnson Fistel's Colorado Office Initiates Investigation on Behalf of Investors
SAN DIEGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a national shareholder rights law firm with an office in Denver, Colorado, has begun investigating potential securities claims on behalf of Biodesix, Inc. (NASDAQ: BDSX) investors following the Company's sharp stock decline on November 6, 2026. The investigation concerns whether Biodesix, a Louisville, Colorado-based diagnostic solutions company, or its officers made materially false or misleading statements or failed to disclose material information to investors.
Biodesix (BDSX) Shares Plunge; Johnson Fistel's Colorado Office Initiates Investigation on Behalf of Investors
Neutral
GlobeNewsWire
10 days ago
Biodesix (BDSX) Shares Plunge; Johnson Fistel's Colorado Office Initiates Investigation on Behalf of Investors
SAN DIEGO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a national shareholder rights law firm with an office in Denver, Colorado, has begun investigating potential securities claims on behalf of Biodesix, Inc. (NASDAQ: BDSX) investors following the Company's sharp stock decline on November 6, 2026. The investigation concerns whether Biodesix, a Louisville, Colorado-based diagnostic solutions company, or its officers made materially false or misleading statements or failed to disclose material information to investors.
Biodesix (BDSX) Shares Plunge; Johnson Fistel's Colorado Office Initiates Investigation on Behalf of Investors
Neutral
Seeking Alpha
11 days ago
Biodesix, Inc. (BDSX) Presents at 2026 UBS Global Healthcare Conference Transcript
Biodesix, Inc. (BDSX) Presents at 2026 UBS Global Healthcare Conference Transcript
Biodesix, Inc. (BDSX) Presents at 2026 UBS Global Healthcare Conference Transcript
Neutral
GlobeNewsWire
12 days ago
BIODESIX, INC. INVESTIGATION: BDSX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Biodesix securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to learn more about your rights.
BIODESIX, INC. INVESTIGATION: BDSX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
Neutral
GlobeNewsWire
13 days ago
Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting
New data highlighting proprietary bioinformatics, ultrasensitive molecular detection, and collaborations with Bio-Rad Laboratories and Thermo Fisher Scientific to advance scalable MRD solutions for clinical laboratories New data highlighting proprietary bioinformatics, ultrasensitive molecular detection, and collaborations with Bio-Rad Laboratories and Thermo Fisher Scientific to advance scalable MRD solutions for clinical laboratories
Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting
Price charts implemented using Lightweight Charts™